Virta Health has launched a unified GLP-1 access platform offering employers multiple fulfilment options, including pharmacy benefit manager, direct-to-employer and direct-to-consumer solutions. All options integrate Virta's provider oversight and nutrition-first weight loss programme. The platform addresses rising GLP-1 costs, which have increased up to 200% annually for some employers. Virta provides cost guarantees including 0% year-over-year GLP-1 utilisation growth and claims-based return on investment. Virta's nutrition-first approach has clinically demonstrated 13% average body weight loss at one year without medication in peer-reviewed studies. More than 75% of Virta's weight loss members currently don't use GLP-1s. The company serves over 700 large self-insured employers.

Virta Health introduces unified GLP-1 access platform for employers. Published on June 10, 2026 New model combines PBM, direct-to-employer, and direct-to-consumer pathways with comprehensive clinical care, giving employers full flexibility without sacrificing accountability. DENVER, Colo. - June 10, 2026 - Virta Health, the leader in reversing metabolic disease, today announced an expanded menu of GLP-1 fulfillment options for employers, spanning pharmacy benefit manager (PBM), direct-to-employer (DTE), and direct-to-consumer (DTC) solutions. Virta pairs these fulfillment options with its proven Responsible Prescribing and Nutrition-first weight loss programs through which members, regardless of the fulfillment option, receive Virta's in-house provider oversight and personalized nutrition guidance to maximize their success. The expansion reflects growing demand from employers and health plans for comprehensive GLP-1 management solutions that offer a great member experience, cost accountability and the best unit prices. Employers continue to navigate a challenging landscape, balancing employee demand for obesity care with rising costs, with GLP-1 expenses increasing by up to 200 percent annually[1] While full PBM coverage can expose employers to uncapped pharmacy spend, fragmented cash-pay arrangements offer limited cost control and often lack the rigorous unified clinical layer needed to drive rapid and sustained health outcomes. Virta gives employers the flexibility to choose the care model and fulfillment option that fits their benefits structure and scope, without taking on open-ended financial risk. Clinical accountability is consistent across all Virta managed programs, regardless of the fulfillment option selected. Every member gets the full benefit of the Virta platform: provider-led clinical support, nutrition-first care, and responsible prescribing designed to maximize GLP-1 effectiveness and pair with medications when clinically appropriate. That consistency underpins Virta's cost guarantees, including a 0% year-over-year GLP-1 utilization growth option, guaranteed weight loss outcomes across enrolled populations, and a 1:1 claims-based return on investment. More than 700 large self-insured employers have already chosen Virta to improve employee health and lower total healthcare costs. "Employers shouldn't have to choose between an uncontrollable spend and fractured clinical care," said Laura Walmsley, Chief Commercial Officer at Virta Health. "With Virta, fulfillment and payment options are their choice while the proven Virta clinical model behind it is the same regardless of which approach they use." Virta's nutrition-first approach supports members with, without and after GLP-1s on their weight loss journey towards better metabolic health. It is the only clinically proven care model to match GLP-1 weight loss outcomes without medication, with members losing an average of 13% of body weight through nutrition alone at one year in peer-reviewed study[2]. More than 75% of Virta's weight loss members are not on GLP-1s[3]. For those who do use the medications, Virta's care model is designed to optimize outcomes and support tapering where appropriate, limiting unnecessary, long-term medication use and its associated costs. Virta prepares members for life-long outcomes beyond GLP-1s, with members sustaining 85% of weight loss beyond medication discontinuation[4]. About Virta Health Virta Health is the leader in reversing metabolic disease. Through their AI-powered individualized nutrition therapy, Virta combines the best of human care with the speed and precision of technology to empower members to build longer, healthier lives, while reducing or eliminating the need for medications. Virta partners with the nation's largest employers, payers, and pharmacy benefit managers to improve the health of their members while reducing costs. Headquartered in Denver, Colorado, Virta is on a bold mission to reverse metabolic disease in one billion people. For more information, visit www.virtahealth.com.

Virta Health targets employer benefits leaders at Aon Total Rewards Summit. According to a recent LinkedIn post from Virta Health, the company plans to participate in Aon's Northeast Total Rewards Summit in New York City on April 29. The post highlights a session titled "Designed for Impact: Evolving the Member Experience," which is positioned as a discussion on what drives sustained engagement with employee benefits. * Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions * Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks Video Muted The post suggests Virta intends to engage directly with benefits leaders on strategies to increase long-term employee utilization of health offerings. For investors, this type of presence at a major rewards-focused event may support business development efforts with large employers and consultants, potentially strengthening Virta's distribution channels in the employer and payer markets. By focusing on "sustained engagement," the session topic aligns with key value drivers in digital health, including outcomes, retention, and return on investment for clients. If Virta can effectively demonstrate higher engagement and impact versus competing solutions, it could enhance its competitive positioning and support pricing power and contract renewals over time. The LinkedIn post also notes informal networking at the summit's welcome event, which may create additional opportunities to build relationships with benefits decision-makers. While the financial impact of a single conference is difficult to quantify, consistent presence at such industry forums can contribute to pipeline development, brand visibility, and long-term growth prospects in the employer benefits segment. Comcast stock (CMCSA) drops on post Q1 analyst updates. Story Highlights * Comcast stock fell on Friday alongside a slew of analyst updates. * These updates followed the company's latest earnings report. Comcast CMCSA -12.90% | stock was down on Friday alongside several analyst updates following the media and technology company's latest earnings report. * Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions * Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks Let's dive into the latest analyst ratings and price targets below. * Morgan Stanley analyst Sean Diffley reiterated a Hold rating and increased his price target to $33 from $31, representing a potential 8.91% upside. * Evercore ISI analyst Kutgun Maral maintained a Buy rating and increased his price target to $36 from $35, representing a potential 18.81% upside. * Five-star Barclays analyst Kannan Venkateshwar reiterated a Hold rating and maintained his price target at $28, representing a potential 7.59% downside. * Five-star Deutsche Bank analyst Bryan Kraft downgraded the stock to Hold and lowered his price target to $34 from $35, representing a potential 12.21% upside. * Five-star RBC Capital analyst Jonathan Atkin kept a Hold rating and increased his price target to $32 from $31, representing a potential 5.61% upside. * Four-star TD Cowen analyst Gregory Williams reiterated a Buy rating and maintained his price target at $39, representing a potential 28.71% upside. * Four-star KeyBanc analyst Brandon Nispel maintained a Hold rating and did not provide a price target. * Five-star Bank of America analyst Jessica Reif Ehrlich reiterated a Buy rating and maintained her price target at $37, representing a potential 22.11% upside. * Five-star Goldman Sachs analyst Mike Ng maintained a Hold rating but increased his price target to $29 from $28, representing a potential 4.29% downside. Comcast stock movement today. Comcast stock was down 5.26% on Friday but was still up 9.45% year-to-date. The stock has fallen 6.67% over the past 12 months. Trading activity today saw some 2.16 million shares change hands, compared to a three-month average daily trading volume of about 32.41 million shares. Is Comcast stock a Buy, Sell, or Hold? Turning to Wall Street, the analysts' consensus rating for Comcast is Hold, based on four Buy, 12 Hold, and two Sell ratings over the past three months. With that comes an average CMCSA stock price target of $32.38, representing a potential 8.24% upside for the shares.